Signal active
Bio
Michael Goguen is the founder and managing partner of Two Bear Capital, a venture capital firm headquartered in Whitefish, Montana and with offices in Boston, San Diego, and the San Francisco Bay area. The firm invests in early stage companies in the areas of biotechnology, bioinformatics, machine learning/AI, and cybersecurity. Prior to founding Two Bear Capital, Mike Goguen spent 20 years as a partner at Sequoia Capital where he led 54 investments to a combined market value of over $64B.
Mike currently serves on the board of Arch Systems, CIQ, Elisity, Graphiant, Inimmune, Leapfrog Bio, Sanavia Oncology, Selector, TileDB, FYR Diagnostics, Novoron Bioscience, and pulseData.
Location
Whitefish, Montana, United States, North America
Social
Primary Organization
2019
20
19
0
11-50
Jobs history
11
Dymium
Board Member
Invalid date - Current
Sequoia Capital
Partner
Invalid date - Current
Abilita Bio
Board Member
2023 - Current
CIQ
Board of Directors
2022 - Current
Two Bear Capital
Founder & Managing Partner
Invalid date - Current
Novoron Bioscience
Board Member
2021 - Current
Elisity
Board Member
2021 - Current
Verafi
Board Member
Invalid date - Current
Graphiant
Board Member
Invalid date - Current
Board Member
2020 - Current
Board Member
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Mike Goguen is the Founder & Managing Partner at Two Bear Capital, based in United States, North America. Mike Goguen studied B.S. Electrical Engineering @ Cornell University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
2
0
Personal investment
2
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Jan 28, 2019 | FYR Diagnostics | Seed Round - FYR Diagnostics | 650.0K |
Mar 26, 2024 | BINARLY | Seed Round - BINARLY | 10.5M |
Partner investment
26
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Mar 28, 2023 | Graphiant | Series B - Graphiant | Two Bear Capital | 62.0M |
Mar 20, 2024 | Dymium | Seed Round - Dymium | Two Bear Capital | 7.0M |
Apr 29, 2024 | Elisity | Series B - Elisity | Two Bear Capital | 45.0M |
Jul 30, 2024 | Montara Therapeutics | Seed Round - Montara Therapeutics | Two Bear Capital | 8.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.